References
- Myers RM, Tilly K, Maniatis T. Fine structure genetic analysis of a beta-globin promoter. Science 1986;232:613–618.
- Rowley PT, Lipkin M Jr, Fisher L. Screening and genetic counseling for beta-thalassemia trait in a population unselected for interest: comparison of three counseling methods. Am J Hum Genet 1984;36:677–689.
- Petrou M. Screening for beta thalassaemia. Indian J Hum Genet 2010;16:1–5.
- Wajcman H, Préhu C, Bardakdjian-Michau J, Promé D, Riou J, Godart C, Mathis M, et al. Abnormal hemoglobins: laboratory methods. Hemoglobin 2001;25:169–181.
- Thein SL. Genetic modifiers of beta-thalassemia. Haematologica 2005;90:649–660.
- Kan YW, Chang JC. Molecular diagnosis of hemoglobinopathies and thalassemia. Prenat Diagn 2010;30:608–610.
- Pornprasert S, Kasemrad C, Sukunthamala K. Diagnosis of thalassemia on dried blood spot samples by high performance liquid chromatography. Hemoglobin 2010;34:486–494.
- Mosca A, Paleari R, Ivaldi G, Galanello R, Giordano PC. The role of haemoglobin A(2) testing in the diagnosis of thalassaemias and related haemoglobinopathies. J Clin Pathol 2009;62:13–17.
- Kalleas C, Tentes I, Margaritis D, Anagnostopoulos K, Toli A, Pendilas D, Bourikas G, et al. Effect of HbS in the determination of HbA(2) with the TOSOH HLC-723G7 analyzer and the HELENA Beta-Thal Quik column kit. Clin Biochem 2007;40:242–247.
- Dell’Edera D, Pacella E, Epifania AA, Benedetto M, Tinelli A, Mazzone E, Laterza F, Malvasi A. Importance of molecular biology in the characterization of beta-thalassemia carriers. Eur Rev Med Pharmacol Sci 2011;15:79–86.
- Passarello C, Giambona A, Cannata M, Vinciguerra M, Renda D, Maggio A. Iron deficiency does not compromise the diagnosis of high HbA(2) ß thalassemia trait. Haematologica 2012;97:472–473.
- Fraser CG, Hyltoft Petersen P, Libeer JC, Ricos C. Proposals for setting generally applicable quality goals solely based on biology. Ann Clin Biochem. 1997;34 ( Pt 1):8–12.